Shenzhen New Industries Biomedical Engineering Balance Sheet Health
Financial Health criteria checks 6/6
Shenzhen New Industries Biomedical Engineering has a total shareholder equity of CN¥8.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥8.8B and CN¥717.1M respectively. Shenzhen New Industries Biomedical Engineering's EBIT is CN¥2.0B making its interest coverage ratio -19.3. It has cash and short-term investments of CN¥2.6B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -19.3x |
| Cash | CN¥2.59b |
| Equity | CN¥8.12b |
| Total liabilities | CN¥717.12m |
| Total assets | CN¥8.84b |
Recent financial health updates
No updates
Recent updates
Investors Shouldn't Overlook The Favourable Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832)
Nov 17
Should You Be Adding Shenzhen New Industries Biomedical Engineering (SZSE:300832) To Your Watchlist Today?
Oct 14Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Aug 25A Look At The Intrinsic Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Jul 01Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today
Apr 09The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence
Mar 18Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Mar 01Financial Position Analysis
Short Term Liabilities: 300832's short term assets (CN¥4.7B) exceed its short term liabilities (CN¥598.6M).
Long Term Liabilities: 300832's short term assets (CN¥4.7B) exceed its long term liabilities (CN¥118.5M).
Debt to Equity History and Analysis
Debt Level: 300832 is debt free.
Reducing Debt: 300832 had no debt 5 years ago.
Debt Coverage: 300832 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300832 has no debt, therefore coverage of interest payments is not a concern.